Clinical outcomes after 2‐year follow‐up of transvaginal radiofrequency ablation of symptomatic uterine fibroids
Journal of Obstetrics and Gynaecology Research · 2025
DOI: 10.1111/jog.16216 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2025. Verfasst von Ángel Santalla-Hernández und 4 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics and Gynecology Department, Virgen de las Nieves University Hospital, Granada, Spain. Hauptthemen laut MEDLINE: Leiomyoma, Radiofrequency Ablation, Uterine Neoplasms, Catheter Ablation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Aim
The aim of this study was to evaluate the efficacy after 2 years follow‐up of transvaginal radiofrequency ablation (TVRA) to treat myomas, and to identify factors predictive of the response to the treatment.
Methods
This is a prospective cohort study of a 2‐year follow‐up of 65 patients who underwent TVRA for the treatment uterine fibroids at Virgen de las Nieves University Hospital in Granada, Spain. Ultrasound mean fibroid volume, symptom severity scale, total bleeding days, complications, pregnancy outcomes were recorded.
Results
Statistically significant improvements in symptoms and bleeding were observed at 6, 12, and 24 months after the procedure. The mean myoma volume (cc) was significantly lower ( p < 0.05) at 12 and 24 months, with a mean reduction in myoma volume of more than 80% and 60%, respectively. After a 24‐month follow‐up, 5 patients (7.7%) required additional surgical treatment to control symptoms. Patient age (>40 years), initial myoma size, and the timing of radiofrequency were identified as factors related to outcomes in the bivariate analysis.
Conclusions
Transvaginal radiofrequency ablation is an effective and safe technique for the treatment of myomas after 2 years of follow‐up, which improves the symptoms of the patients and decreases the final volume of the myoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Obstetrics and Gynecology Department, Virgen de las Nieves University Hospital, Granada, Spain.
- Quantitative Methods Department, Statistical, CUNEF University, Madrid, Spain.
ORCID-Profile: Ángel Santalla-Hernández, Roi Naveiro-Flores
Zitieren
APA
Santalla-Hernández, Á., Naveiro-Fuentes, M., López-Criado, M. S., Naveiro-Flores, R., & Fernández-Parra, J. (2025). Clinical outcomes after 2‐year follow‐up of transvaginal radiofrequency ablation of symptomatic uterine fibroids. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.16216
Vancouver
Santalla-Hernández Á, Naveiro-Fuentes M, López-Criado MS, Naveiro-Flores R, Fernández-Parra J. Clinical outcomes after 2‐year follow‐up of transvaginal radiofrequency ablation of symptomatic uterine fibroids. Journal of Obstetrics and Gynaecology Research. 2025. doi:10.1111/jog.16216
BibTeX
@article{SantallaHernndez2025,
author = {Santalla-Hernández, Ángel and Naveiro-Fuentes, Mariña and López-Criado, María Setefilla and Naveiro-Flores, Roi and Fernández-Parra, Jorge},
title = {Clinical outcomes after 2‐year follow‐up of transvaginal radiofrequency ablation of symptomatic uterine fibroids},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2025},
doi = {10.1111/jog.16216}
}
EUVIMED